Biopharmaceutical company focused on oncology and autoimmune diseases
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Cullinan Therapeutics, Inc. in the last 30 days yet.
The 1 sources with the most insights about Cullinan Therapeutics, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Trading at a discount ($15) relative to a recent private placement price ($19) paid by smart money investors.
Trading at a discount ($15) relative to a recent private placement price ($19) paid by smart money investors.
Other assets that creators frequently mention in the same content as Cullinan Therapeutics, Inc..
The most active sources covering Cullinan Therapeutics, Inc. (CGEM) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Cullinan Therapeutics, Inc. (CGEM) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Cullinan Therapeutics, Inc. (CGEM) most frequently also discuss BTC, 000660, PCVX, SLNO, VKTX. See the "Discussed alongside" section above for full asset pages.